You are here: Industry Insights > GSK

News List

GSK’s chief financial officer to retire pharmatimes
July 09, 2018
GlaxoSmithKline has announced that its chief financial officer Simon Dingemans is to retire.
Trump’s U.K. visit sparks plans for mass protests—and dinner invites for GSK, J&J CEOs fiercepharma
July 06, 2018
But some business leaders say they’re skeptical the gathering will go forward, according to the report.
GSK Director indicted in Massachusetts opioid lawsuit pharmafile
July 06, 2018
The state of Massachusetts has taken action to sue a board member at GlaxoSmithKline for her alleged role in fuelling the opioid addiction crisis that has devastated the United States in recent years.
GSK takes billion-dollar drug fight with Gilead to top AIDS meeting financialexpress
June 29, 2018
GlaxoSmithKline is taking its fight with Gilead Sciences for dominance of the HIV market to the world’s leading AIDS conference next month by showcasing detailed results from its new two-drug treatment.
GSK Receives FDA Approval of Arnuity Ellipta for Asthma in Children From 5 Years of Age drugs
May 31, 2018
GSK today announced it has received approval from the US Food and Drug Administration (FDA) for the use of Arnuity Ellipta (fluticasone furoate) a once-daily inhaled corticosteroid (ICS) medicine for the maintenance treatment of asthma in children from as
FiercePharmaAsia—Astellas job cuts, GSK vet’s $260M Chinese startup, Sun's Zytiga knockoff fiercepharma
May 28, 2018
Astellas' new CEO is pushing for a round of layoffs in RD and sales and marketing that will cost 600 jobs. GlaxoSmit
GSK’s CFO chooses to exit company pharmafile
May 10, 2018
Simon Dingemans has been Chief Financial Officer at GSK since 2011 but has now chosen to retire from the position this time next year.
GSK strengthens core prescription business with Sin hire pharmaphorum
April 28, 2018
In a drive to boost its search for innovative products worldwide, GlaxoSmithKline (GSK) has hired Kevin Sin from Roche.
GSK’s Shingles Vaccine is Bright Spot in First Quarter of 2018 biospace
April 26, 2018
Despite strong sales of shingles vaccine Shingrix, GlaxoSmithKline reported its sales and earnings fell 2 percent in the first quarter of the year, largely due to...
GSK picks Kevin Sim to lead business development for pharma R&D pharmatimes
April 20, 2018
GlaxoSmithKline has named Kevin Sim as senior vice president and head of worldwide business development for pharmaceuticals R&D.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page